Measuring the Potential Health Impact of Personalized Medicine: Evidence from Multiple Sclerosis Treatments
A chapter in Economic Dimensions of Personalized and Precision Medicine, 2018, pp 185-216 from National Bureau of Economic Research, Inc
JEL-codes: I1 I10 I11 O3 O31 (search for similar items in EconPapers)
References: View references in EconPapers View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:nbr:nberch:13990
Ordering information: This item can be ordered from
Access Statistics for this chapter
More chapters in NBER Chapters from National Bureau of Economic Research, Inc National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.. Contact information at EDIRC.
Bibliographic data for series maintained by ().